For decades, pharmaceutical procurement created value through negotiation - the next value stream will be driven by understanding.
In a USD 600 billion-plus industry, the cost of APIs, excipients, biologics inputs, and specialty chemicals is no longer set by supplier pricing alone; it is shaped by an interconnected web of manufacturing realities - yields, energy intensity, compliance, utilization, and supply-chain resilience. Yet most sourcing still relies on prices, quotes, and benchmarks, giving buyers visibility into what suppliers charge, but not why those costs exist.
Two suppliers can quote the same number for entirely different cost realities - because a price is an outcome, not an explanation. This POV explores how closing that gap is becoming the real source of cost leadership.
Download the POV.